← Back to Search

Behavioral Intervention

Future Thinking Intervention for Smoking and Bipolar Disorder

N/A

Waitlist Available

Led By Alexandra K Gold, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of BD I or II

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week: 1, 2, 3, 4, 5, 6, 10

Awards & highlights

No Placebo-Only Group

Summary

This trial involves a 6-session online program called Future Self-BD that helps people imagine positive future events that can be improved by quitting smoking. The sessions will be held on a secure video platform and

Who is the study for?

This trial is for individuals who struggle with both tobacco use and bipolar disorder. Participants should be willing to attend six virtual sessions via a secure Zoom platform, led by the study's principal investigator.

What is being tested?

The intervention being tested is called Future Self-BD, which consists of six online sessions aimed at helping participants envision positive future events that could result from quitting smoking.

What are the potential side effects?

Since this is a behavioral therapy session conducted virtually, there are no direct medical side effects like those associated with medication or surgical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Bipolar Disorder I or II.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week: 1, 2, 3, 4, 5, 6, 10

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week: 1, 2, 3, 4, 5, 6, 10

This trial's timeline: 3 weeks for screening, Varies for treatment, and week: 1, 2, 3, 4, 5, 6, 10 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability

Feasibility

Secondary study objectives

Participant Motivation to Quit Smoking

Seeking Smoking Cessation Treatment as Assessed by The Seeking Smoking Cessation Treatment Questionnaire

Self-Efficacy to Resist Smoking as Assessed by the Smoking Self-Efficacy Questionnaire(SEQ-12)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Future Self-BDExperimental Treatment1 Intervention

Experimental Arm utilizing the Future Self-BD Intervention.The Future Self group will attend 6 virtual sessions during which they will be encouraged to vividly generate personal and positive future events that they anticipate may be benefited by smoking cessation. All participants will complete the adjusting amount discounting task. All participants will also receive brief, CBT-based smoking cessation counseling. This group will involve one follow-up session one month after the sixth session. Each session will be conducted on HIPAA-compliant Zoom and led by the PI, Dr. Gold.

Group II: Daily Check-InsActive Control1 Intervention

Active comparator arm utilizing Daily Check-Ins (DCI). The DCI group will attend 6 virtual sessions during which they will complete the adjusting amount discounting task and receive brief, CBT-based smoking cessation counseling (consistent with counseling received by Future Self-BD). This group will involve one follow-up session one month after the sixth session. Each session will be conducted on HIPAA-compliant Zoom and led by the PI, Dr. Gold.

0 / 1Eligibility criteria met